Critical Milestones Achieved Ahead of Schedule in Lung Cancer Study

Case Study

February 1, 2019
Critical Milestones Achieved Ahead of Schedule in Lung Cancer Study
This case study summarizes how IQVIA Biotech helped a biotechnology company reach critical milestones as it prepared to launch an international Phase III clinical trial for its investigational anaplastic lymphoma kinase (ALK) inhibitor in patients with non-small cell lung cancer (NSCLC).